When to stop human chorionic gonadotrophin (hCG) surveillance after treatment with chemotherapy for gestational trophoblastic neoplasia (GTN): A national analysis on over 4,000 patients.

Kirsty Balachandran,Abdulazeez Salawu,Ehsan Ghorani,Baljeet Kaur,Neil J Sebire,Dee Short,Richard Harvey,Barry Hancock,John Tidy,Kamaljit Singh,Naveed Sarwar,Matthew C Winter,Michael J Seckl

Gynecologic Oncology（2019）

引用 42|浏览21

暂无评分

摘要

•Recurrence rate of 4.7% observed in this cohort of over 4000 patients with Gestational Trophoblastic Neoplasia.•No relapses observed beyond seven years following treatment for GTN in this dataset.•New national policy recommends patients now continue hCG screening for 10 years only.

查看译文

关键词

Gestational trophoblastic neoplasia,Human chorionic gonadotrophin,Surveillance,Recurrence

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要